Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer

BACKGROUND: FOLFIRINOX prolongs survival in patients with metastatic pancreatic cancer and may also benefit patients with locally advanced pancreatic cancer (LAPC). Furthermore, it may downstage a proportion of LAPC into (borderline) resectable disease, however data are lacking. This review assessed...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Surg Oncol
Main Authors: Rombouts, Steffi J., Walma, Marieke S., Vogel, Jantien A., van Rijssen, Lennart B., Wilmink, Johanna W., Mohammad, Nadia Haj, van Santvoort, Hjalmar C., Molenaar, I. Quintus, Besselink, Marc G.
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2016
Assuntos:
Gastrointestinal Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5090009/
https://ncbi.nlm.nih.gov/pubmed/27370653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-016-5373-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares